Scarica l'app Stockscreener
10.11
0.10%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.07
Aprire:
$10.06
Volume 24 ore:
33,506
Relative Volume:
0.18
Capitalizzazione di mercato:
$240.56M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-7.2214
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
+10.77%
1M Prestazione:
+15.46%
6M Prestazione:
-4.18%
1 anno Prestazione:
+18.31%
Intervallo 1D:
$10.04
$10.29
Intervallo di 1 settimana:
$9.23
$10.29
Portata 52W:
$6.90
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
10.11 | 240.56M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
129.85 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.19 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
365.03 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.84 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.27 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
Russell Investments Group Ltd. Acquires 2,324 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Geode Capital Management LLC Raises Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025 - Stock Titan
Avita Uses Its Tech To Treat Wounds - Los Angeles Business Journal
AVITA Medical to Announce First Quarter 2025 Financial Results - The Manila Times
AVITA Medical to Announce First Quarter 2025 Financial Results | RCEL Stock News - GuruFocus
Leading Wound Care Company AVITA Medical Announces Q1 2025 Earnings Call Details - Stock Titan
The new medical device company to watch - Morningstar
Vanguard Group Inc. Has $18.22 Million Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. Announces Chief Executive Officer Changes - marketscreener.com
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc.'s (NASDAQ:RCEL) Profit Outlook - simplywall.st
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 | RCEL Stock News - GuruFocus
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - The Manila Times
AVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Major Clinical Breakthrough: New Data From 6,000 Patients Transforms Burn Treatment - Stock Titan
6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga
AVITA Medical launches Cohealyx in the U.S. market By Investing.com - Investing.com India
AVITA Medical Announces US Commercial Launch Of Cohealyx - marketscreener.com
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener
AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times
AVITA Medical launches Cohealyx in the U.S. market - Investing.com
Game-Changing Wound Care: AVITA's New Cohealyx Shows Superior Healing Results - Stock Titan
Avita Medical stock hits 52-week low at $7.44 amid market challenges - Investing.com Canada
Long Term Trading Analysis for (RCEL) - news.stocktradersdaily.com
Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect? - MSN
Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Grows By 35.8% - MarketBeat
AVITA Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Investors overly negative on undervalued ASX share - Morningstar.com.au
Global healthcare stocks for your watchlist - Morningstar Australia
AVITA Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital - The AM Reporter
AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com
AVITA Medical signs manufacturing deal with Stedical Scientific for PermeaDerm - MSN
AVITA Medical (NASDAQ:RCEL) Receives “Buy” Rating from D. Boral Capital - Defense World
What Analysts Are Saying About AVITA Medical Stock - Benzinga
AVITA Secures Manufacturing, Amends Distribution Agreement with US-Based Healthcare Tech Provider; Shares Rise 7% - Marketscreener.com
AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements - The Capital Club
Avita Medical Boosts Production with New Agreement - TipRanks
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific - The Manila Times
(RCEL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Skin Burns Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight - The Globe and Mail
Investors Don't See Light At End Of AVITA Medical, Inc.'s (NASDAQ:RCEL) Tunnel - Simply Wall St
How To Trade (RCEL) - Stock Traders Daily
Avita Medical LimitedADR to Host Earnings Call - ACCESS Newswire
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - The Manila Times
Can AVITA Medical's Conference Appearance Signal New Growth Opportunities in Wound Care? - StockTitan
Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):